Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lucid Diagnostics (LUCD) Shares Outstanding (2021 - 2025)

Lucid Diagnostics (LUCD) has disclosed Shares Outstanding for 5 consecutive years, with $130.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding rose 153.74% year-over-year to $130.9 million, compared with a TTM value of $130.9 million through Sep 2025, up 153.74%, and an annual FY2024 reading of $54419.0, down 99.87% over the prior year.
  • Shares Outstanding was $130.9 million for Q3 2025 at Lucid Diagnostics, up from $54419.0 in the prior quarter.
  • Across five years, Shares Outstanding topped out at $130.9 million in Q3 2025 and bottomed at $13625.0 in Q1 2023.
  • Average Shares Outstanding over 5 years is $33.0 million, with a median of $34.9 million recorded in 2021.
  • The sharpest move saw Shares Outstanding tumbled 99.96% in 2023, then skyrocketed 378598.85% in 2024.
  • Year by year, Shares Outstanding stood at $34.9 million in 2021, then grew by 16.04% to $40.5 million in 2022, then rose by 4.47% to $42.3 million in 2023, then crashed by 99.87% to $54419.0 in 2024, then skyrocketed by 240486.35% to $130.9 million in 2025.
  • Business Quant data shows Shares Outstanding for LUCD at $130.9 million in Q3 2025, $54419.0 in Q2 2025, and $84.4 million in Q1 2025.